|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trading debt securities | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Deferred financing costs | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Short-term notes payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total short-term notes payable | ||||||||||||||||||||
| Current portion of interest payable due to related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total current portion of interest payable due to related parties | ||||||||||||||||||||
| Current portion of royalties payable | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Convertible notes payable, at fair value | ||||||||||||||||||||
| Short-term notes | ||||||||||||||||||||
| Short-term notes payable of variable interest entities due to related parties | ||||||||||||||||||||
| Deferred consideration | ||||||||||||||||||||
| Deferred stock issuance liability | ||||||||||||||||||||
| Current portion of royalties payable due to related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total current portion of royalties payable due to related parties | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Royalties payable | ||||||||||||||||||||
| Notes payable due to related parties | ||||||||||||||||||||
| Royalties payable due to related parties | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Notes payable of variable interest entities, net of discount | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total notes payable of variable interest entities, net of discount | ||||||||||||||||||||
| Interest payable due to related parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total interest payable due to related parties | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Preferred Stock | ||||||||||||||||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized; 3,609,471 and 1,738,955 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity attributable to Catheter Precision, Inc. | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...